'On/Off' Science Careers Are Gaining Favor

There is a growing market out there for part-time and/or temporary work in the sciences. Employers have long seen the advantages—savings in overhead and benefits plus greater flexibility in many activities—but now the practice of research is changing, moving toward almost interchangeable scientists performing routine, clearly divided tasks. At the same time, based on our work in the professional relations office of the American Chemical Society I see an increasing interest in this

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

At the same time, based on our work in the professional relations office of the American Chemical Society I see an increasing interest in this kind of arrangement among certain groups of scientists. We are moving toward an era of “modularity” of career stages: a preference for easy-in, easy-out, easy-return jobs.

Several forces are making part-time science feasible. As an example, the high-tech end of industrial chemistry is becoming more of a service industry. More chemists are not handling chemicals, but are creating information about highly engineered materials.

With this kind of activity work will be less tied to monitoring processes. And with automated laboratories, there will be even less demand for the chemist to be in a particular place at a particular time.

If we look at the economics, more market-driven research programs will mean less continuity of research effort and will make ad-hoc puzzle-solving teams more attractive. Employers ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Terrence Russell

    This person does not yet have a bio.

Published In

Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

sartorius logo
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo

Products

Photo of a researcher overseeing large scale production processes in a laboratory.

Scaling Lentiviral Vector Manufacturing for Optimal Productivity

Thermo Fisher Logo
Collage-style urban graphic of wastewater surveillance and treatment

Putting Pathogens to the Test with Wastewater Surveillance

An illustration of an mRNA molecule in front of a multicolored background.

Generating High-Quality mRNA for In Vivo Delivery with lipid nanoparticles

Thermo Fisher Logo
Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide